Low-dose cyproterone acetate plus mini-dose diethylstilbestrol - A protocol for reversible medical castration

Urology

Volumn 47, Issue 6, 1996, Pages 882-884

  Goldenberg, S Larry ^a,b   Bruchovsky, N ^a   Gleave, M E ^a   Sullivan, L D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE; DIETHYLSTILBESTROL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER HORMONE THERAPY; CASTRATION; DEEP VEIN THROMBOSIS; DEPRESSION; FATIGUE; GYNECOMASTIA; HOT FLUSH; HUMAN; JAUNDICE; LIBIDO; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; SEXUAL FUNCTION;

EID: 0029896055     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00048-9     Document Type: Article

References (3)

1. Goldenberg SL, Bruchovsky N, Rennie PS, and Coppin CM: The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma. J Urol 140: 1460-1465, 1988.
2. Goldenberg SL, Bruchovsky N, Gleave ME, Sullivan LD, and Akakura K: Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report. Urology 45: 839-845, 1995.
3. Akakura K, Bruchovsky N, Goldenberg SL, Rennie PS, Buckley AR, and Sullivan LD: Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen. Cancer 71: 2782-2790, 1993.